The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CERRITOS, Calif., Sept. 15, 2022 - The Oncology Institute, Inc. (NASDAQ: TOI) announced that its CEO, Brad Hively, will join the panel on 'Next Frontier - Value Based Care for Sub-Capitation/Specialties' at the Nephron 2nd Annual Physician Enablement Symposium on September 22 at 9:00 am EST. Founded in 2007, TOI is one of the largest value-based oncology groups in the U.S., serving around 1.7 million patients through over 50 clinic locations, employing more than 90 clinicians.
Details
News Market Reaction – TOI
The recorded move for TOI in the trading session of this news was -7.62%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate on the “Next Frontier - Value Based Care for Sub-Capitation/Specialties” panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22 at 9:00am EST.
About The Oncology Institute, Inc.
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Contacts
Media
The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com
(562) 735-3226 x 88806
Revive
Michael Petrone
mpetrone@reviveagency.com
(615) 760-4542
Investors
Solebury Trout
Maria Lycouris
investors@theoncologyinstitute.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.